Skip to content

Starting antiretroviral treatment does not reduce the incidence or prevalence of cervical infection with human papillomavirus

Adding drugs to already successful HIV treatment doesn't reduce viral load further

Targeted viral load tests in India prevent switches to second-line ARVs for one in four

Adherence key to reducing genital HIV levels in women

Low CD4 cell count associated with heart attack in patients with HIV

Individual risk factors crucial in determining a patient's risk of heart attack if taking abacavir

Detectable genital HIV shedding associated with cervical infections appears minimal among women taking ART

Infectious and non-infectious lung disease risk increased for those with HIV

Treatment with tenofovir associated with more bone loss than abacavir, but long-term consequences unclear